Petrova G 1

1. Cost-effectiveness of cardiomyopathy ambulatory care with sacubitril/valsartan vs standard therapy after COVID-19 in Kazakhstan
2. Quality of life of patients with cardiomyopathy treated with sacubitril/valsartan vs. standard therapy during or after COVID-19 in Kazakhstan
3. Transferability of Real World Evidence to Support HTA Recommendations in Lower Income European Countries
4. Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study
1